X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2023/10/18/2762296/0/en/Baudax-Bio-Announces-Corporate-Update.html
https://www.globenewswire.com//news-release/2023/09/28/2751180/0/en/Baudax-Bio-Announces-Orphan-Drug-Designation-Granted-by-U-S-FDA-for-TI-168-for-the-Treatment-of-Hemophilia-A-with-Inhibitors.html
https://www.globenewswire.com//news-release/2023/09/07/2739292/0/en/Baudax-Bio-to-Participate-in-the-H-C-Wainwright-Global-Investment-Conference.html
https://www.globenewswire.com//news-release/2023/08/23/2730353/0/en/Baudax-Bio-Announces-Distribution-of-Series-C-Preferred-Stock-to-Holders-of-its-Common-Stock.html
https://www.globenewswire.com//news-release/2023/08/17/2727199/0/en/Baudax-Bio-Announces-1-9-Million-Registered-Direct-Offering-Priced-At-The-Market-under-Nasdaq-Rules.html
https://www.globenewswire.com//news-release/2023/08/16/2726283/0/en/Baudax-Bio-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2023/06/30/2697710/0/en/Baudax-Bio-Acquires-TeraImmune-Inc.html
https://www.clinicaltrialsarena.com/news/baudax-bio-reports-promising-additional-data-for-neuromuscular-blockade-agent/
https://www.globenewswire.com/news-release/2023/06/07/2683858/0/en/Baudax-Bio-Announces-Additional-Positive-Top-Line-Results-From-Phase-2-Randomized-Clinical-Trial-of-BX1000.html
https://www.globenewswire.com/news-release/2023/06/06/2682905/0/en/Baudax-Bio-Announces-Date-of-Reconvened-Annual-Meeting.html
Market Place
Share 
